TrialThe international journal of neuropsychopharmacology2018

A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.

Richard S E Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.